<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The FOLFOX regimen is approved as an adjuvant therapy for <z:hpo ids='HP_0003003'>colon cancer</z:hpo> in Japan </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of pathological damage in the resected non-cancerous liver after 12 courses of mFOLFOX6 therapy as an adjuvant therapy for stage IIIb <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>A 45-year-old man underwent laparoscopic right hemicolectomy for ascending <z:hpo ids='HP_0003003'>colon cancer</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>After completing 12 courses of adjuvant mFOLFOX6 therapy, this patient exhibited <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Lateral segment resection was performed, and pathological examination of the resected specimen revealed irregular sinusoidal <z:mpath ids='MPATH_66'>dilatation</z:mpath> and cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> in the non-tumorous part of the liver </plain></SENT>
<SENT sid="5" pm="."><plain>This was probably due to the effects of mFOLFOX6 </plain></SENT>
<SENT sid="6" pm="."><plain>We stress that when resectable <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> is found after 12 courses of FOLFOX as an adjuvant therapy for <z:hpo ids='HP_0003003'>colon cancer</z:hpo>, careful attention should be paid during surgery and during postsurgical management because there may be damage in the remnant liver </plain></SENT>
</text></document>